[Pneumonia and mortality in patients requiring prolonged mechanical ventilation]. 1996

J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
Department of Internal Medicine, Kawasaki Medical School, Japan.

We examined patients who required prolonged (>60 days) mechanical ventilation. A total of 31 patients were studied, 23 with pulmonary disease, 4 with neurologic disease and 4 with other conditions. Many of these patients were elderly. The survival rates one year and two years after the start of mechanical ventilation were 40% and 33%, respectively. Respiratory tract infection was the most common and most serious complication, and ventilator-associated pneumonia was the main cause of death. It is difficult but quite important to prevent these complications, especially ventilator-associated pneumonia.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D012121 Respiration, Artificial Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2). Ventilation, Mechanical,Mechanical Ventilation,Artificial Respiration,Artificial Respirations,Mechanical Ventilations,Respirations, Artificial,Ventilations, Mechanical
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
August 2022, Journal of intensive care medicine,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
July 2008, Critical care medicine,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
May 1995, Chest,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
July 2023, Intensive care medicine,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
February 2005, Microbes and infection,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
January 2011, Tuberkuloz ve toraks,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
March 2023, Medicina (Kaunas, Lithuania),
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
March 2020, Scientific reports,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
June 2012, Respiratory care,
J Tanabe, and H Yoneyama, and Y Kobashi, and M Taniguchi, and A Higo, and T Yano, and M Kimura, and Y Tano, and T Matsushima
December 1999, Anaesthesia and intensive care,
Copied contents to your clipboard!